RE:TLT updated the corporate presentation Feb 7 2022 The 90 day data seems the same as last Q report. So probably they are waiting for more results at end of month? For next Quarterly?
Interesting bit on NSCLC .. "Rutherrin® + X-Ray Activation leads to a 3 log kill of human NSCLC cells in-vitro"
A 3 log kill is 99.9% Tumor cell kill. A Tumor with 10^9 cells( a Billion cells) is reduced to 10^6 ( a million cells. Extremely effective IMO. They can retreat as well and add immune response for extra overall efficacy .
https://www.brainkart.com/article/The-Log-Cell-Kill-Hypothesis_28418/
DJDawg wrote:
I'm sure there are some details in there that represent updates. They include BDT aproval in later 2022 which is interesting. Suggests may not be an imminent announcement but also suggests a high degree of confidence.
https://theralase.com/wp-content/uploads/2022/02/Corporate-PPT-020722.pdf